| Drug Type AAV based gene therapy | 
| Synonyms rAAV-Mediated TCAP Gene | 
| Target | 
| Action modulators | 
| Mechanism telethonin modulators(titin-cap modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Muscular Dystrophy, Limb-Girdle, Type 2G | Preclinical | United States  | - | |
| Muscular Dystrophy, Limb-Girdle, Type 2G | Preclinical | United States  | - | 





